The co-founder of Regeneron has warned that blockbuster weight-loss drugs could cause “more harm than good” unless the rapid muscle loss associated with the treatments is solved, as the US biotech pushes ahead with trials of muscle-preserving medicines.
再生元(Regeneron)的聯(lián)合創(chuàng)始人警告稱，除非解決與治療相關(guān)的快速肌肉流失問(wèn)題，否則暢銷的減肥藥物可能會(huì)“弊大于利”，因?yàn)槊绹?guó)生物技術(shù)公司正在推進(jìn)保肌藥物的試驗(yàn)。
您已閱讀7%（338字），剩余93%（4297字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。